![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Ablative Solutions’ Infusion Catheter Snags CE Mark
Ablative Solutions’ Infusion Catheter Snags CE Mark
![](https://www.fdanews.com/ext/resources/test/Device_Images4/BP.jpg?t=1433878514&width=430)
Ablative Solutions’s Peregrine system infusion catheter for hypertension has won CE Mark approval, the Kalamazoo, Calif., devicemaker announced Wednesday.
The device works by infusing a neurolytic agent into the perivascular space surrounding the renal artery, which targets high blood pressure-causing sympathetic nerves. The company has begun enrolling drug-resistant hypertension patients in a European clinical trial.
The devicemaker also plans a trial in the U.S., where the product has been designated investigational use only for hypertension. — Jason Scott
Upcoming Events
-
21Oct